These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6778190)

  • 1. Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.
    Maloney JD; Nissen RG; McColgan JM
    Am Heart J; 1980 Dec; 100(6 Pt 2):1023-30. PubMed ID: 6778190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide success.
    Winkle RA; Mason JW; Harrison DC
    Am Heart J; 1980 Dec; 100(6 Pt 2):1031-6. PubMed ID: 6778191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocainide therapy for refractory ventricular arrhythmias.
    Roden DM; Roden DM; Reele SB; Reele SB; Higgins SB; Higgins SB; Carr RK; Carr RK; Smith RF; Smith RF; Oates JA; Oates JA; Woosley RL; Woosley RL
    Am Heart J; 1980 Jul; 100(1):15-22. PubMed ID: 6770666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocainide for refractory ventricular arrhythmias of myocardial infarction.
    Haffajee CI; Alpert JS; Dalen JE
    Am Heart J; 1980 Dec; 100(6 Pt 2):1013-6. PubMed ID: 6778188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ventricular arrhythmias with oral tocainide.
    Young MD; Hadidian Z; Horn HR; Johnson JL; Vassallo HG
    Am Heart J; 1980 Dec; 100(6 Pt 2):1041-5. PubMed ID: 6778193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocainide for drug-resistant sustained ventricular tachyarrhythmias.
    Adhar GC; Swerdlow CD; Lance BL; Clay D; Bardy GH; Greene HL
    J Am Coll Cardiol; 1988 Jan; 11(1):124-31. PubMed ID: 3121711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of tocainide and quinidine for better tolerance and additive effects in patients with coronary artery disease.
    Kim SG; Mercando AD; Fisher JD
    J Am Coll Cardiol; 1987 Jun; 9(6):1369-74. PubMed ID: 3108345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction.
    Nyquist O; Forssell G; Nordlander R; Schenck-Gustafsson K
    Am Heart J; 1980 Dec; 100(6 Pt 2):1000-5. PubMed ID: 6778186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.
    Mason JW; Peters FA
    Circulation; 1981 Mar; 63(3):670-5. PubMed ID: 6780234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmias.
    Hohnloser SH; Lange HW; Raeder EA; Podrid PJ; Lown B
    Circulation; 1986 Jan; 73(1):143-9. PubMed ID: 3079677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
    Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
    Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.